Key Takeaways
- Alcon shares gained over 3% following an upward revision to full-year earnings projections
- The eye care company lowered its 2026 tariff exposure forecast to $40M-$90M from $100M-$150M
- A projected $60M reimbursement from the U.S. government contributed to the reduced tariff estimate
- Core diluted EPS outlook increased to 12%-15% growth, marking the second upward adjustment this year
- Second-quarter revenue reached $2.78B, surpassing analyst projections, with adjusted EPS of $0.84 versus $0.75 expected
Shares of Alcon experienced a significant uptick exceeding 3% on Monday after the Swiss-American eye care specialist enhanced its annual earnings forecast and lowered its projected tariff costs for 2026.
The equity was trading up over 3% at 08:24 GMT in response to the news.
The company has revised its core diluted earnings per share growth projection to a range of 12% to 15% for the current year. This represents an increase from the 10% to 13% range provided in May and constitutes the second upward revision to this performance indicator in 2026.
Additionally, Alcon broadened its expectations for core operating profit margin expansion. The company now anticipates margin improvement between 90 and 190 basis points for the full year, up from the earlier projection of 70 to 170 basis points.
The outlook for full-year revenue growth remained steady at 5% to 7% on a constant currency basis.
Tariff Exposure Reduced by More Than Half
Among the most significant updates was the revised tariff assessment. Alcon has adjusted its full-year tariff impact projection to a range of $40 million to $90 million, a substantial decrease from the previously estimated $100 million to $150 million.
This revision primarily reflects an expected reimbursement of approximately $60 million from the U.S. government.
The United States represents a critical market for Alcon, generating 45% of total revenue during the first six months of the year. The company also operates most of its primary manufacturing sites in the U.S., which mitigates some of the supply chain vulnerabilities that affect other global firms.
Second Quarter Performance Exceeds Expectations
Revenue for the second quarter totaled $2.78 billion, representing an increase from $2.58 billion during the corresponding period last year. This figure marginally exceeded the analyst consensus compiled by LSEG.
Adjusted earnings per share for the quarter reached $0.84, outperforming the IBES estimate of $0.75.
Company leadership attributed the strong performance to successful new product introductions and effective commercial strategies.
The core operating margin for the second quarter stood at 20.6%.
Both the enhanced guidance and revised tariff outlook were announced in conjunction with the second-quarter financial results released late Monday.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
